Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy

被引：0
|
作者：
Keane, F. [1 ]
Cowzer, D. [1 ]
Khalil, D. [1 ]
Shia, J. [1 ]
Do, R. [1 ]
Folorunso, S. [1 ]
El Dika, I. [1 ]
Yaqubie, A. [1 ]
Kim, T. [1 ]
O'Reilly, E. [1 ]
Abou-Alfa, G. [2 ,3 ]
Harding, J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Cornell Univ, Dept Med, Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Cornell Univ, Weill Med Coll, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-272
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [21] Routine assessment of cardiotoxicity in patients undergoing long-term immune checkpoint inhibitor therapy
    Tamura, Yudai
    Tamura, Yuichi
    Yamada, Kenta
    Taniguchi, Hirohisa
    Iwasawa, Jin
    Yada, Hirotaka
    Kawamura, Akio
    [J]. HEART AND VESSELS, 2022, 37 (11) : 1859 - 1865
  • [22] Routine assessment of cardiotoxicity in patients undergoing long-term immune checkpoint inhibitor therapy
    Yudai Tamura
    Yuichi Tamura
    Kenta Yamada
    Hirohisa Taniguchi
    Jin Iwasawa
    Hirotaka Yada
    Akio Kawamura
    [J]. Heart and Vessels, 2022, 37 : 1859 - 1865
  • [23] Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
    Talukder, Rafee
    Makrakis, Dimitrios
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Dawsey, Scott
    Gupta, Shilpa
    Carril-Ajuria, Lucia
    Castellano, Daniel
    de Kouchkovsky, Ivan
    Jindal, Tanya
    Koshkin, Vadim S.
    Park, Joseph J.
    Alva, Ajjai
    Bilen, Mehmet A.
    Stewart, Tyler F.
    McKay, Rana R.
    Tripathi, Nishita
    Agarwal, Neeraj
    Vather-Wu, Naomi
    Zakharia, Yousef
    Morales-Barrera, Rafael
    Devitt, Michael E.
    Cortellini, Alessio
    Fulgenzi, Claudia Angela Maria
    Pinato, David J.
    Nelson, Ariel
    Hoimes, Christopher J.
    Gupta, Kavita
    Gartrell, Benjamin A.
    Sankin, Alex
    Tripathi, Abhishek
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Murgic, Jure
    Frobe, Ana
    Rodriguez-Vida, Alejo
    Drakaki, Alexandra
    Liu, Sandy
    Lu, Eric
    Kumar, Vivek
    Di Lorenzo, Giuseppe
    Joshi, Monika
    Isaacsson-Velho, Pedro
    Buznego, Lucia Alonso
    Duran, Ignacio
    Moses, Marcus
    Barata, Pedro
    Sonpavde, Guru
    Wright, Jonathan L.
    Yu, Evan Y.
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : 558 - 567
  • [24] Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts).
    Nizam, Amanda
    Tzeng, Alice
    Wei, Wei
    Rayman, Patricia A.
    Pavicic, Paul G.
    Makarov, Vladimir
    Juric, Ivan
    Alban, Tyler
    Swaidani, Shadi
    Sheng, Iris Yeong-Fung
    Gilligan, Timothy D.
    Gupta, Shilpa
    Diaz-Montero, C. Marcela
    Ornstein, Moshe Chaim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [25] Conversion therapy with an immune checkpoint inhibitor and an antiangiogenic drug for advanced hepatocellular carcinoma: A review
    Tang, Haowen
    Cao, Yinbiao
    Jian, Yiping
    Li, Xuerui
    Li, Junfeng
    Zhang, Wenwen
    Wan, Tao
    Liu, Zhe
    Tang, Wei
    Lu, Shichun
    [J]. BIOSCIENCE TRENDS, 2022, 16 (02) : 130 - 141
  • [26] Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
    Talukder, Rafee
    Bakaloudi, Dimitra Rafailia
    Lin, Genevieve Ihsiu
    Enright, Tom
    Leary, Jacob Beck
    Makrakis, Dimitrios
    Tripathi, Nishita
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Brown, Jason R.
    Johnson, Jeffrey
    Zakharia, Yousef
    Park, Joseph J.
    Alva, Ajjai Shivaram
    Barrera, Rafael Morales
    Drakaki, Alexandra
    Barata, Pedro C.
    Khaki, Ali Raza
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Extended linifanib therapy in patients (pts) with advanced hepatocellular carcinoma (HCC) in a phase II trial
    Chen, P. J.
    Yong, W.
    Carr, B. I.
    Sato, T.
    Qin, Q.
    Qian, J.
    Ansell, P. J.
    McKeegan, E. M.
    McKee, M. D.
    Ricker, J. L.
    Carlson, D. M.
    Toh, H. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Outcomes following long-term response to immune checkpoint inhibitors in patients with advanced melanoma
    Handel, Eleanor
    McKeown, Janet
    Wei, Joe
    Kankaria, Roma
    Burnette, Hannah
    Lawless, Aleigha
    Czapla, Juliane
    Albrecht, Lea Jessica
    Mangana, Joanna
    Kessels, Jolien Isabel
    Allayous, Clara
    Boatwright, Christina Ann
    Ottaviano, Margaret
    Czarnecka, Anna Malgorzata
    Rutkowski, Piotr
    Lo, Serigne N.
    Long, Georgina V.
    Menzies, Alexander M.
    Carlino, Matteo S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts)
    Sahin, Ibrahim Halil
    Goyal, Subir
    Pumpalova, Yoanna S.
    Sonbol, Mohamad Bassam
    Das, Satya
    Haraldsdottir, Sigurdis
    Chen, Zhengjia
    Akce, Mehmet
    Alese, Olatunji B.
    Shaib, Walid Labib
    Ahn, Daniel H.
    Ciombor, Kristen Keon
    Berlin, Jordan
    Bekaii-Saab, Tanios S.
    Draper, Amber
    Lesinski, Gregory B.
    El-Rayes, Bassel F.
    Wu, Christina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] Hepatocellular carcinoma: Long-term outcomes in patients with HCC after radioembolization
    Hutchinson E.
    [J]. Nature Reviews Gastroenterology & Hepatology, 2010, 7 (3) : 123 - 123
12345